Approval · Notice of Compliance 733 · 2002
XENICAL: Notice of Compliance 733
Issued February 8, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 733
- Date
- February 8, 2002
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Priority
- Reason
- New indication: for use in combination with anti-diabetic agents to improve blood glucose control in overweight or obese type 2 diabetes patients
- Therapeutic class
- Anti-obesity agent/gastrointestinal lipase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XENICAL | Not yet assigned | — |
Medicinal ingredients
- ORLISTAT 120 MG per CAP